Tesamorelin

Unlike direct growth hormone administration, Tesamorelin works through physiological stimulation of the GH axis, preserving normal pulsatile secretion. It is clinically recognized for reducing visceral adipose tissue and improving metabolic markers. It has been widely studied in patients with abdominal fat accumulation and metabolic disturbances.

By enhancing natural GH production, Tesamorelin supports fat metabolism, lean body mass preservation, and cellular repair processes.

• Reduces visceral abdominal fat

• Supports lean muscle mass maintenance

• Enhances metabolic function

• Improves lipid profile parameters

• Supports cellular regeneration

• May improve liver fat markers

• Contributes to better body composition

• Supports healthy IGF-1 regulation

• May enhance recovery capacity

• Supports overall metabolic resilience

Tesamorelin has been evaluated in randomized clinical trials for reduction of visceral adipose tissue. Studies demonstrated significant decreases in abdominal fat and improvements in lipid profiles and inflammatory markers.

Research confirms that Tesamorelin increases endogenous growth hormone and IGF-1 within physiological ranges. Clinical investigations also showed improvements in body composition and metabolic health parameters.

• Recommended dose: 1 mg daily in the evening, before bedtime and 1–2 hours after meals

• Correct dose in units: 20 units per day

• Frequency & course duration: Once daily for 2–6 weeks

• Pause: 1 month break after cycle

Unit conversion

One pen contains 200 units /2 ml:

• 1 unit = 0.05 mg (50 mcg)

• 20 units = 1 mg

One Tesamorelin pen lasts approximately 10 days.

If following the label cycle (2–6 weeks), you would need:

• 2-week cycle → 2 pens

• 4-week cycle → 3 pens

• 6-week cycle → 5 pens

Apply to abdominal area or front thigh. Rotate application sites. Hold the device in place for 10 seconds before removal.

Peptides Commonly Combined with Tesamorelin:

• Ipamorelin – synergistic GH stimulation

• CJC-1295 No DAC – enhanced GH pulsatility

• HGH Frag 176-191 – targeted fat metabolism

• MOTS-C – metabolic optimisation support

• Mild injection site irritation

• Temporary water retention

• Headache

• Mild flushing

These effects are typically dose-dependent and reversible.

This compound is intended strictly for personal observation and research-related purposes. The information presented is based on scientific literature and is not intended to diagnose, treat, or prevent any medical conditions.